Talking therapy and brain training versus adding a memory medication for early Alzheimer's

This trial is testing whether adding donepezil to standard brain training and therapy helps people with newly diagnosed Alzheimer's disease better than brain training alone. You would be randomly assigned to receive either brain training with therapy as usual, or the same brain training and therapy plus daily donepezil tablets. The goal is to understand whether this medication, combined with these supportive treatments, makes a meaningful difference in how people manage their symptoms.

Alzheimer's disease currently has no cure, and doctors are looking for the best ways to help people in the early stages slow down memory and thinking problems. This trial exists to see whether this medication, when used alongside brain training and therapy, offers patients better outcomes than these supportive approaches alone.